At the 31 March 2017 funding valuation date, the aggregate of the deficits across the UK schemes was £2.1bn, broadly similar to the position at the last valuation in 2014.
The current annual deficit recovery payments of c£205m will increase by £15m to c£220m in 2018. Deficit contributions will further increase in line with any percentage growth in dividend payments made by the BAE Systems group (the “Group”).
Under the new deficit recovery plans, these annual payments would subsequently fall by c£50m in 2022 and end in 2026.
The schemes’ liabilities have been calculated using an asset led discount approach. Liabilities have also reduced due to both actual and forecast mortality rates since the last valuation.
The agreements reached are underpinned by contingency plans. These include a commitment by the Group to a further £50m of deficit funding into the largest scheme prior to the next triennial valuation in the event that the scheme funding level was to fall below pre-determined parameters.
The next triennial funding valuation and review of contingency plans is scheduled for 2020.
For completeness, the annual deficit contributions into the Group’s US schemes are expected to remain at $80m through 2022.
